Related Experiment Video
Updated: Aug 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Period prevalence and case-fatality rate associated with distinctive clone complexes of Neisseria meningitidis
E S Jensen1, L Berthelsen, I Lind
1Department of Clinical Epidemiology, Aalborg Hospital, 2nd Floor, Stengade 10, 9000 Aalborg, Denmark. esjensen@dadlnet.dk
Abstract:
In a recent 20-year Danish survey, Neisseria meningitidis phenotypes B:15:P1.7,16 and C:2a:P1.2,5 were associated with an increased case-fatality rate of meningococcal disease - 15% and 23% - compared to the case-fatality rate of 8% for any other strain. The aim of the present study was to investigate (i) the mutual genetic relatedness of strains with phenotype B:15:P1.7,16, phenotype C:2a:P1.2,5 or serologically related phenotypes; (ii) the changes in the prevalence of distinctive clone complexes over time; and (iii) whether distinctive clone complexes are associated with an increased case-fatality rate. During the period 1980-1999, 181 of a total of 315 invasive strains obtained in North Jutland County, Denmark, were chosen on the basis of serological characteristics for characterization by multilocus enzyme electrophoresis and ribotyping. Two major complexes were identified on the basis of electrophoretic type (ET): the ET-4/23 complex ( n=111), which included all B:15:P1.7,16 strains ( n=100), and the ET-15/25 complex ( n=44), which included all C:2a:P1.2,5 strains ( n=31). Two ribotype complexes were identified within the ET-4/23 complex and one within the ET-15/25 complex, all of which were designated clone complexes. All three clone complexes were associated with an increased case-fatality rate (13-20%). The results show that, among invasive Neisseria meningitidis B:15:P1.7,16, C:2a:P1.2,5 and phenotypically related strains, three distinctive clone complexes are more virulent than any other ET/ribotype combination.
Insights
Certain Neisseria meningitidis strains, specifically B:15:P1.7,16 and C:2a:P1.2,5, show higher fatality rates. Three distinct clone complexes within these strains are linked to increased virulence and case-fatality in meningococcal disease.
Area of Science:
- Microbiology
- Epidemiology
- Genetics
Background:
- Neisseria meningitidis is a significant cause of bacterial meningitis.
- Specific serogroups and phenotypes of N. meningitidis have been linked to increased disease severity and mortality.
- A Danish survey identified B:15:P1.7,16 and C:2a:P1.2,5 phenotypes with higher case-fatality rates.
Purpose of the Study:
- To investigate the genetic relatedness of virulent N. meningitidis strains.
- To analyze temporal changes in the prevalence of specific clone complexes.
- To determine if these clone complexes are associated with increased case-fatality rates.
Main Methods:
- Multilocus enzyme electrophoresis (MEE) and ribotyping were used for strain characterization.
- 181 invasive N. meningitidis strains from North Jutland County (1980-1999) were analyzed based on serological characteristics.
- Electrophoretic types (ETs) and ribotypes were used to define clone complexes.
Main Results:
- Two major electrophoretic type (ET) complexes were identified: ET-4/23 (including B:15:P1.7,16 strains) and ET-15/25 (including C:2a:P1.2,5 strains).
- Three distinct clone complexes were identified within these major ET complexes.
- All three identified clone complexes were associated with significantly increased case-fatality rates (13-20%) compared to other strains.
Conclusions:
- Three specific clone complexes within Neisseria meningitidis B:15:P1.7,16 and C:2a:P1.2,5 strains demonstrate enhanced virulence.
- These virulent clone complexes pose a greater risk for severe outcomes in meningococcal disease.
- Understanding the genetic makeup of highly virulent meningococcal strains is crucial for public health interventions.
Related Concept Videos
Bacterial Meningitis
Atypical Pneumonia
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

